End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.25 THB | 0.00% | -0.62% | 0.00% |
Business Summary
Sales per Business
THB in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Brands
52.8
%
| 8,331 | 53.1 % | 8,287 | 52.8 % | -0.53% |
Distribution
45.4
%
| 7,041 | 44.9 % | 7,115 | 45.4 % | +1.05% |
Original Equipment Manufacture
1.8
%
| 314 | 2.0 % | 279 | 1.8 % | -10.98% |
Sales per region
THB in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South East Asia
87.7
%
| 13,693 | 87.3 % | 13,755 | 87.7 % | +0.46% |
Others
6.2
%
| 1,044 | 6.7 % | 965 | 6.2 % | -7.62% |
Sub-Saharan Africa
6.1
%
| 949 | 6.0 % | 961 | 6.1 % | +1.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Vivek Dhawan
CEO | Chief Executive Officer | 62 | 01/86/01 |
Thomas Abraham
DFI | Director of Finance/CFO | 59 | 01/97/01 |
Jonnara Reddy
COO | Chief Operating Officer | - | - |
Deepak Panjwani
CMP | Compliance Officer | - | - |
Manoj Gurbuxani
PRN | Corporate Officer/Principal | 49 | 01/10/01 |
Corporate Secretary | 51 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Vijay Karwal
BRD | Director/Board Member | 53 | 13/21/13 |
Founder | 70 | 01/82/01 | |
Chi Yim Kam
BRD | Director/Board Member | 67 | 01/13/01 |
Director/Board Member | 58 | 01/13/01 | |
Vivek Dhawan
CEO | Chief Executive Officer | 62 | 01/86/01 |
Thor Santhisiri
BRD | Director/Board Member | 71 | 01/13/01 |
Chairman | 83 | 01/13/01 | |
Sameera Shah
BRD | Director/Board Member | 40 | 01/13/01 |
Thomas Abraham
DFI | Director of Finance/CFO | 59 | 01/97/01 |
Director/Board Member | 57 | 05/23/05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 871,869,508 | 330,598,620 ( 37.92 %) | 0 | 37.92 % |
Company contact information
Mega Lifesciences Public Co. Ltd.
909 Ample Tower 9th Floor, Debaratna Road
10260, Bangna
+
http://www.megawecare.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 970M | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- MEGA Stock
- Company Mega Lifesciences